Palliative intra-arterial (i.a.) chemotherapy with carboplatin (CBDCA) and 5-FU in unresectable advanced (stage III and IV) head and neck cancer using implantable port-systems

1995 ◽  
Vol 21 (5) ◽  
pp. 486-489 ◽  
Author(s):  
A. Eckardt ◽  
A. Kelber ◽  
C. Pytlik
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Neck Cancer ◽  
Stage Iii ◽  
Advanced Stage ◽  
Port Systems ◽  
Implantable Port

scholarly journals OUTCOME OF LOCALLY ADVANCED STAGE III AND IV HEAD AND NECK CANCER TREATED BY SURGERY AND POSTOPERATIVE EXTERNAL BEAM RADIOTHERAPY

1987 ◽  
Vol 97 (5) ◽  
pp. 615???620 ◽  
Author(s):  
P. PRADEEP KUMAR ◽  
ROGER R. GOOD ◽  
BARRY E. EPSTEIN ◽  
ANTHONY J. YONKERS ◽  
F. PAUL OGREN ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Neck Cancer ◽  
External Beam Radiotherapy ◽  
Locally Advanced ◽  
Stage Iii ◽  
External Beam ◽  
Advanced Stage

Analysis of dysphagia in advanced-stage head-and-neck cancer patients: impact on quality of life and development of a preventive swallowing treatment

2018 ◽  
Vol 275 (8) ◽  
pp. 2159-2167 ◽  
Author(s):  
Ilaria Carmignani ◽  
Luca Giovanni Locatello ◽  
Isacco Desideri ◽  
Pierluigi Bonomo ◽  
Emanuela Olmetto ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Head And Neck Cancer ◽  
Head And Neck ◽  
Cancer Patients ◽  
Neck Cancer ◽  
Advanced Stage

Guideline - Adherence in advanced stage head and neck cancer is associated with improved survival – A National study

Oral Oncology ◽  
2022 ◽  
Vol 125 ◽  
pp. 105694
Author(s):  
Oded Cohen ◽  
Philip R. Brauer ◽  
Benjamin L. Judson ◽  
Barbara A. Burtness ◽  
Joseph Earles ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Neck Cancer ◽  
Guideline Adherence ◽  
National Study ◽  
Advanced Stage

Prognostic value of body composition on recurrence and survival of advanced-stage head and neck cancer

2019 ◽  
Vol 116 ◽  
pp. 98-106 ◽  
Author(s):  
Ah Ra Jung ◽  
Jong-Lyel Roh ◽  
Jae Seung Kim ◽  
Sung-Bae Kim ◽  
Seung-Ho Choi ◽  
...  
Keyword(s):  
Body Composition ◽  
Head And Neck Cancer ◽  
Head And Neck ◽  
Neck Cancer ◽  
Prognostic Value ◽  
Advanced Stage

Combined therapy for stage III-IV head and neck cancer: preliminary results.

1984 ◽  
Vol 2 (7) ◽  
pp. 804-810 ◽  
Author(s):  
S H Krasnow ◽  
M H Cohen ◽  
A Johnston-Early ◽  
M L Citron ◽  
B E Fossieck ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Neck Cancer ◽  
Response Rate ◽  
Combined Modality Therapy ◽  
Combined Therapy ◽  
Stage Iii ◽  
Combined Modality Treatment ◽  
Combined Modality ◽  
Rbc Deformability

As part of a combined modality treatment program using chemotherapy, surgery, and/or radiotherapy, 25 patients with previously untreated stage III or IV head and neck cancer received initial combination chemotherapy. Pathologically confirmed complete remission was noted in nine patients (36%). The overall objective major response rate (with all patients included in analysis) was 68%. The chemotherapy regimen included bleomycin, cisplatin, vinblastine, methotrexate, and 5-fluorouracil. A novel concept of drug scheduling was used, based on chemotherapy-induced improvement in RBC deformability. The underlying concept is that improved RBC deformability results in improved capillary blood flow and thereby, increased drug delivery to tumor cells. Treatment resulted in moderate hematologic and renal toxicity with no treatment-related deaths. This exceptionally high, pathologically confirmed complete response rate will hopefully provide a mechanism by which combined modality therapy can adequately be tested for its ability to prolong survival of patients with advanced head and neck cancer.

Sign in / Sign up

Export Citation Format

Share Document